Results 21 to 30 of about 1,077,721 (136)

‘So many relationships in the room’: Participant perspectives on the affordances and challenges of co‐therapy in psychedelic assisted therapy [PDF]

open access: yesPsychology and Psychotherapy: Theory, Research and Practice, Volume 99, Issue 4, Page 1604-1626, December 2026.
Abstract Objectives Psychedelic‐assisted therapy (PAT) frequently utilises a “cotherapy” model, in which two therapists jointly support participants throughout dosing and psychotherapy sessions. While common in clinical trials, participant experiences of cotherapy remain underexplored.
Rachel Ham   +3 more
wiley   +2 more sources

Psychedelic assisted psychotherapy (2020–2025): a scoping review of clinical evidence, mechanisms, safety, and ethics [PDF]

open access: yesFrontiers in Psychology
BackgroundClinical research on psychedelic-assisted therapy (PAT) has expanded substantially in recent years, particularly for post-traumatic stress disorder (PTSD) and depressive disorders.
Nasiru Mohammed Abdullahi   +23 more
doaj   +2 more sources

Psychedelics in Mental Health: Opportunities and Challenges [PDF]

open access: yesBrain and Behavior, Volume 16, Issue 7, July 2026.
ABSTRACT Psychedelic and substance‐assisted therapies are attracting renewed scientific, clinical, and public interest as potential interventions for mental health disorders, particularly treatment‐resistant depression, post‐traumatic stress disorder, and substance use disorders.
Lena K. L. Oestreich, Nathalie M. Rieser
wiley   +2 more sources

Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from Jamaica [PDF]

open access: yesFrontiers in Psychiatry
We report two case studies that examine the therapeutic potential of structured psilocybin-containing mushroom biomass regimens administered within a clinical framework, evaluating their impact on mental health outcomes as well as associated somatic ...
Caitlyn Hanna Sams   +6 more
doaj   +2 more sources

Therapeutic use of psilocybin: Practical considerations for dosing and administration

open access: yesFrontiers in Psychiatry, 2022
The interest in psilocybin as a therapeutic approach has grown exponentially in recent years. Despite increasing access, there remains a lack of practical guidance on the topic for health care professionals.
Caroline A. MacCallum   +3 more
doaj   +1 more source

A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol

open access: yesEuropean Psychiatry, 2023
Introduction During the last decade there has been a resurgence of interest on the use of psychedelics as novel treatments for mental disorders, including treatment-resistant depression (TRD). Psilocybin, the chemical component of “magic mushrooms”, has
M. I. Husain   +6 more
doaj   +1 more source

Will psilocybin lose its magic in the clinical setting?

open access: yesTherapeutic Advances in Psychopharmacology, 2022
Psilocybin as a novel treatment for depression is garnering a lot of attention from both the mainstream media and the academic community. Although phase 3 trials are only just beginning, we feel that it is important for clinicians to consider what ...
Caroline Hayes   +2 more
doaj   +1 more source

The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions

open access: yesFrontiers in Pharmacology, 2018
Research on the clinical applications of psychedelic-assisted psychotherapy has demonstrated promising early results for treatment of alcohol dependence.
Elizabeth M. Nielson   +3 more
doaj   +1 more source

Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?

open access: yesPharmaceuticals, 2022
Psilocybin has been suggested as a promising transdiagnostic treatment strategy for a wide range of psychiatric disorders. Recent findings showed that psychedelic-assisted/”psycholitic” psychotherapy should provide significant and sustained alleviation ...
Antonio Munafò   +5 more
doaj   +1 more source

Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience [PDF]

open access: yes, 2020
Attachment insecurity is determined early in life, is a risk factor for psychopathology, and can be measured on two separate continuous dimensions: attachment anxiety and attachment avoidance.
Stauffer, Christopher S   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy